TG Therapeutics Inc (TGTX) — Cash Flow-to-Debt Ratio
TG Therapeutics Inc (TGTX) has a Cash Flow-to-Debt Ratio of -0.02x as of March 2026, meaning its operating cash flow of $-17.89 Million could theoretically repay 0% of its total liabilities ($945.71 Million) in one year. Explore investment intensity of TG Therapeutics Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TG Therapeutics Inc Cash Flow-to-Debt Ratio (1996–2025)
Historical debt coverage capacity for TG Therapeutics Inc across 30 annual periods. Also explore TGTX asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for TG Therapeutics Inc (1996–2025)
Year-by-year debt coverage analysis for TG Therapeutics Inc. For market capitalisation and broader financial context, see market value of TG Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | $-24.77 Million | $415.23 Million | ▲ +47.7% |
| 2024 | -0.11x | $-40.52 Million | $355.33 Million | ▲ +38.6% |
| 2023 | -0.19x | $-31.41 Million | $169.09 Million | ▲ +85.8% |
| 2022 | -1.31x | $-176.17 Million | $134.99 Million | ▲ +37.1% |
| 2021 | -2.07x | $-295.63 Million | $142.48 Million | ▼ -2.8% |
| 2020 | -2.02x | $-214.51 Million | $106.29 Million | ▼ -89.0% |
| 2019 | -1.07x | $-132.81 Million | $124.40 Million | ▲ +50.7% |
| 2018 | -2.16x | $-128.93 Million | $59.58 Million | ▼ -124.7% |
| 2017 | -0.96x | $-93.76 Million | $97.38 Million | ▲ +14.4% |
| 2016 | -1.12x | $-61.59 Million | $54.78 Million | ▼ -185.5% |
| 2015 | -0.39x | $-44.69 Million | $113.47 Million | ▲ +2.6% |
| 2014 | -0.40x | $-35.06 Million | $86.75 Million | ▼ -79.6% |
| 2013 | -0.22x | $-10.82 Million | $48.11 Million | ▲ +71.7% |
| 2012 | -0.80x | $-5.19 Million | $6.52 Million | ▼ -5660.2% |
| 2011 | -0.01x | $-86.58K | $6.27 Million | ▲ +83.2% |
| 2010 | -0.08x | $-1.97 Million | $24.00 Million | ▲ +44.1% |
| 2009 | -0.15x | $-1.05 Million | $7.15 Million | ▲ +81.4% |
| 2008 | -0.79x | $-4.44 Million | $5.62 Million | ▲ +85.5% |
| 2007 | -5.47x | $-10.23 Million | $1.87 Million | ▼ -37.0% |
| 2006 | -3.99x | $-7.75 Million | $1.94 Million | ▼ -6.4% |
| 2005 | -3.75x | $-6.24 Million | $1.67 Million | ▲ +21.2% |
| 2004 | -4.76x | $-5.69 Million | $1.20 Million | ▼ -33.2% |
| 2003 | -3.57x | $-3.45 Million | $966.02K | ▼ -44.1% |
| 2002 | -2.48x | $-1.43 Million | $577.73K | ▲ +71.8% |
| 2001 | -8.80x | $-4.47 Million | $508.61K | ▼ -1487.3% |
| 2000 | -0.55x | $-1.15 Million | $2.08 Million | ▲ +85.5% |
| 1999 | -3.83x | $-2.30 Million | $600.00K | ▲ +11.5% |
| 1998 | -4.33x | $-2.60 Million | $600.00K | ▲ +57.7% |
| 1997 | -10.25x | $-4.10 Million | $400.00K | ▲ +23.1% |
| 1996 | -13.33x | $-4.00 Million | $300.00K | — |